|
2025-01-23 |
2025-01-21 |
V
Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
4.000
-1.3%
9,00
36.000 USD
|
4.000
-1.3%
|
9,00
|
36.000 USD
|
|
|
2024-11-13 |
2024-11-11 |
V
Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
4.000
-1.2%
9,00
36.000 USD
|
4.000
-1.2%
|
9,00
|
36.000 USD
|
|
|
2024-08-09 |
2024-08-07 |
K
Kauf
|
Samaha Eli
Large shareholder
|
999.800
+11.7%
7,80
7.798.440 USD
|
999.800
+11.7%
|
7,80
|
7.798.440 USD
|
|
|
2024-07-12 |
2024-07-10 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
4.000
-1.2%
9,00
36.000 USD
|
4.000
-1.2%
|
9,00
|
36.000 USD
|
|
|
2024-05-03 |
2024-05-01 |
K
Kauf
|
Samaha Eli
Large shareholder
|
499.324
+6.2%
8,75
4.369.085 USD
|
499.324
+6.2%
|
8,75
|
4.369.085 USD
|
|
|
2024-05-03 |
2024-05-01 |
K
Kauf
|
Samaha Eli
Large shareholder
|
999.800
+14.3%
8,75
8.748.250 USD
|
999.800
+14.3%
|
8,75
|
8.748.250 USD
|
|
|
2024-02-22 |
2024-02-22 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
1.254
-0.4%
8,71
10.922 USD
|
1.254
-0.4%
|
8,71
|
10.922 USD
|
|
|
2023-11-22 |
2023-11-21 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
1.378
-0.4%
10,29
14.180 USD
|
1.378
-0.4%
|
10,29
|
14.180 USD
|
|
|
2023-11-16 |
2023-11-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.482
-0.7%
10,22
25.366 USD
|
2.482
-0.7%
|
10,22
|
25.366 USD
|
|
|
2023-10-18 |
2023-10-16 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.482
-0.7%
9,03
22.412 USD
|
2.482
-0.7%
|
9,03
|
22.412 USD
|
|
|
2023-09-18 |
2023-09-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.482
-0.7%
9,89
24.547 USD
|
2.482
-0.7%
|
9,89
|
24.547 USD
|
|
|
2023-08-24 |
2023-08-22 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
1.807
-0.5%
9,47
17.112 USD
|
1.807
-0.5%
|
9,47
|
17.112 USD
|
|
|
2023-08-15 |
2023-08-11 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.322
-0.7%
9,99
23.197 USD
|
2.322
-0.7%
|
9,99
|
23.197 USD
|
|
|
2023-07-18 |
2023-07-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.322
-0.7%
9,84
22.848 USD
|
2.322
-0.7%
|
9,84
|
22.848 USD
|
|
|
2023-06-16 |
2023-06-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.322
-0.7%
10,69
24.822 USD
|
2.322
-0.7%
|
10,69
|
24.822 USD
|
|
|
2023-06-12 |
2023-06-08 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
1.790
-0.5%
11,13
19.923 USD
|
1.790
-0.5%
|
11,13
|
19.923 USD
|
|
|
2023-05-17 |
2023-05-15 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.322
-0.6%
11,26
26.146 USD
|
2.322
-0.6%
|
11,26
|
26.146 USD
|
|
|
2023-04-18 |
2023-04-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.323
-0.6%
11,88
27.597 USD
|
2.323
-0.6%
|
11,88
|
27.597 USD
|
|
|
2023-03-16 |
2023-03-14 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.323
-0.6%
10,32
23.973 USD
|
2.323
-0.6%
|
10,32
|
23.973 USD
|
|
|
2023-03-13 |
2023-03-09 |
V
Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
4.000
-1.1%
10,20
40.800 USD
|
4.000
-1.1%
|
10,20
|
40.800 USD
|
|
|
2023-03-08 |
2023-03-06 |
GV
Geplanter Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.323
-0.6%
10,05
23.346 USD
|
2.323
-0.6%
|
10,05
|
23.346 USD
|
|
|
2022-12-16 |
2022-12-14 |
V
Verkauf
|
Winningham Rick E
CHIEF EXECUTIVE OFFICER
Geschäftsführender Verwaltungsratsmitglied
|
50.000
-3.6%
11,19
559.500 USD
|
50.000
-3.6%
|
11,19
|
559.500 USD
|
|
|
2022-12-05 |
2022-12-01 |
V
Verkauf
|
GRAHAM RICHARD A
SVP, RESEARCH & DEVELOPMENT
Führungsperson
|
2.084
-0.7%
10,73
22.361 USD
|
2.084
-0.7%
|
10,73
|
22.361 USD
|
|
|
2022-11-22 |
2022-11-18 |
V
Verkauf
|
Hindman Andrew A.
SVP, CHIEF FINANCIAL OFFICER
Führungsperson
|
65.000
-13.7%
11,02
716.242 USD
|
65.000
-13.7%
|
11,02
|
716.242 USD
|
|
|
2022-08-18 |
2022-08-16 |
V
Verkauf
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Führungsperson
|
4.906
-1.3%
9,71
47.640 USD
|
4.906
-1.3%
|
9,71
|
47.640 USD
|
|
|
2022-08-11 |
2022-08-09 |
V
Verkauf
|
GRAHAM RICHARD A
SVP, DEVELOPMENT
Führungsperson
|
15.086
-3.9%
8,79
132.606 USD
|
15.086
-3.9%
|
8,79
|
132.606 USD
|
|
|
2022-05-24 |
2022-05-23 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
1.081
-0.3%
8,93
9.653 USD
|
1.081
-0.3%
|
8,93
|
9.653 USD
|
|
|
2022-03-02 |
2022-02-28 |
GV
Geplanter Verkauf
|
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Führungsperson
|
2.356
-0.7%
10,16
23.947 USD
|
2.356
-0.7%
|
10,16
|
23.947 USD
|
|
|
2021-03-11 |
2021-03-09 |
V
Verkauf
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Führungsperson
|
8.829
-2.5%
20,00
176.580 USD
|
8.829
-2.5%
|
20,00
|
176.580 USD
|
|
|
2020-12-16 |
2020-12-14 |
V
Verkauf
|
GRAHAM RICHARD A
SVP, Development
Führungsperson
|
7.500
-5.7%
19,47
146.058 USD
|
7.500
-5.7%
|
19,47
|
146.058 USD
|
|
|
2020-12-07 |
2020-12-03 |
V
Verkauf
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Führungsperson
|
4.246
-1.3%
18,00
76.428 USD
|
4.246
-1.3%
|
18,00
|
76.428 USD
|
|
|
2020-08-24 |
2020-08-21 |
V
Verkauf
|
HAUMANN BRETT K
Chief Medical Officer
Führungsperson
|
25.000
-8.1%
18,29
457.240 USD
|
25.000
-8.1%
|
18,29
|
457.240 USD
|
|
|
2020-08-24 |
2020-08-20 |
V
Verkauf
|
WORBOYS PHILIP D
SVP, Research & Transl Science
Führungsperson
|
17.103
-4.9%
18,00
307.854 USD
|
17.103
-4.9%
|
18,00
|
307.854 USD
|
|
|
2019-12-16 |
2019-12-12 |
V
Verkauf
|
SABESAN VIJAY
SVP, Technical Operations
Führungsperson
|
1.027
-0.7%
21,03
21.598 USD
|
1.027
-0.7%
|
21,03
|
21.598 USD
|
|
|
2019-05-20 |
2019-05-17 |
V
Verkauf
|
O'Connor Donal
|
2.673
-8.8%
20,19
53.968 USD
|
2.673
-8.8%
|
20,19
|
53.968 USD
|
|
|
2019-05-20 |
2019-05-16 |
V
Verkauf
|
O'Connor Donal
|
1.327
-4.2%
21,00
27.867 USD
|
1.327
-4.2%
|
21,00
|
27.867 USD
|
|
|
2019-03-06 |
2019-03-05 |
V
Verkauf
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
5.690
-2.1%
24,50
139.405 USD
|
5.690
-2.1%
|
24,50
|
139.405 USD
|
|
|
2019-03-06 |
2019-03-04 |
V
Verkauf
|
HEGDE SHARATHCHANDRA S
SVP, Research
|
3.343
-1.2%
25,06
83.764 USD
|
3.343
-1.2%
|
25,06
|
83.764 USD
|
|
|
2018-09-14 |
2018-09-12 |
V
Verkauf
|
WORBOYS PHILIP D
SVP, Translational Science
Führungsperson
|
6.393
-3.7%
28,50
182.201 USD
|
6.393
-3.7%
|
28,50
|
182.201 USD
|
|
|
2018-08-29 |
2018-08-27 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
7.119
-7.8%
27,71
197.282 USD
|
7.119
-7.8%
|
27,71
|
197.282 USD
|
|
|
2018-08-16 |
2018-08-15 |
V
Verkauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
1.700
-1.0%
27,43
46.623 USD
|
1.700
-1.0%
|
27,43
|
46.623 USD
|
|
|
2018-08-16 |
2018-08-15 |
V
Verkauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
39.839
-18.7%
26,71
1.064.032 USD
|
39.839
-18.7%
|
26,71
|
1.064.032 USD
|
|
|
2018-08-16 |
2018-08-14 |
V
Verkauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
2.204
-1.0%
27,74
61.136 USD
|
2.204
-1.0%
|
27,74
|
61.136 USD
|
|
|
2018-08-09 |
2018-08-08 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
25.355
-20.5%
27,85
706.182 USD
|
25.355
-20.5%
|
27,85
|
706.182 USD
|
|
|
2018-08-09 |
2018-08-07 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
4.127
-3.2%
28,03
115.686 USD
|
4.127
-3.2%
|
28,03
|
115.686 USD
|
|
|
2018-08-09 |
2018-08-07 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
1.818
-1.4%
28,99
52.707 USD
|
1.818
-1.4%
|
28,99
|
52.707 USD
|
|
|
2018-06-08 |
2018-06-08 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
3.900
-2.9%
23,66
92.260 USD
|
3.900
-2.9%
|
23,66
|
92.260 USD
|
|
|
2018-06-08 |
2018-06-06 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
10.140
-7.1%
24,09
244.268 USD
|
10.140
-7.1%
|
24,09
|
244.268 USD
|
|
|
2018-05-23 |
2018-05-21 |
K
Kauf
|
MALKIEL BURTON G
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.000
+1.8%
22,54
22.540 USD
|
1.000
+1.8%
|
22,54
|
22.540 USD
|
|
|
2018-05-22 |
2018-05-18 |
V
Verkauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
10.000
-4.1%
24,29
242.877 USD
|
10.000
-4.1%
|
24,29
|
242.877 USD
|
|
|
2017-09-08 |
2017-09-06 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
14.670
-9.8%
30,77
451.350 USD
|
14.670
-9.8%
|
30,77
|
451.350 USD
|
|
|
2017-08-23 |
2017-08-21 |
K
Kauf
|
PASQUALONE FRANK
SVP, Chief Comm Ops Officer
|
4.000
+1.9%
26,34
105.359 USD
|
4.000
+1.9%
|
26,34
|
105.359 USD
|
|
|
2017-08-14 |
2017-08-11 |
K
Kauf
|
MALKIEL BURTON G
|
15.000
+inf%
24,59
368.816 USD
|
15.000
+inf%
|
24,59
|
368.816 USD
|
|
|
2017-08-14 |
2017-08-11 |
K
Kauf
|
MALKIEL BURTON G
|
15.000
+46.1%
24,59
368.855 USD
|
15.000
+46.1%
|
24,59
|
368.855 USD
|
|
|
2017-08-14 |
2017-08-11 |
K
Kauf
|
WHITESIDES GEORGE M
|
4.000
+inf%
24,69
98.764 USD
|
4.000
+inf%
|
24,69
|
98.764 USD
|
|
|
2017-08-11 |
2017-08-11 |
K
Kauf
|
Fore Henrietta
|
6.000
+33.3%
23,99
143.932 USD
|
6.000
+33.3%
|
23,99
|
143.932 USD
|
|
|
2017-08-11 |
2017-08-11 |
K
Kauf
|
Winningham Rick E
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
10.000
+1.2%
24,50
245.000 USD
|
10.000
+1.2%
|
24,50
|
245.000 USD
|
|
|
2017-03-08 |
2017-03-07 |
V
Verkauf
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
424
-0.3%
30,80
13.059 USD
|
424
-0.3%
|
30,80
|
13.059 USD
|
|
|
2017-03-08 |
2017-03-06 |
V
Verkauf
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
|
13.576
-7.6%
31,52
427.916 USD
|
13.576
-7.6%
|
31,52
|
427.916 USD
|
|
|
2017-03-07 |
2017-03-03 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
|
26.829
-14.2%
31,86
854.772 USD
|
26.829
-14.2%
|
31,86
|
854.772 USD
|
|
|
2016-08-25 |
2016-08-25 |
V
Verkauf
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Führungsperson
|
4.491
-2.3%
27,99
125.703 USD
|
4.491
-2.3%
|
27,99
|
125.703 USD
|
|
|
2016-08-22 |
2016-08-22 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
37.078
-15.9%
27,16
1.007.038 USD
|
37.078
-15.9%
|
27,16
|
1.007.038 USD
|
|
|
2016-08-23 |
2016-08-19 |
V
Verkauf
|
HAUMANN BRETT K
SVP Clin Dev & Chief Med Ofc
Führungsperson
|
9.509
-4.6%
27,97
265.967 USD
|
9.509
-4.6%
|
27,97
|
265.967 USD
|
|
|
2016-08-22 |
2016-08-19 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
4.870
-2.0%
28,14
137.042 USD
|
4.870
-2.0%
|
28,14
|
137.042 USD
|
|
|
2016-08-22 |
2016-08-18 |
V
Verkauf
|
Shafer Bradford J
EVP, Gen. Counsel, Secretary
Führungsperson
|
7.174
-2.9%
28,55
204.818 USD
|
7.174
-2.9%
|
28,55
|
204.818 USD
|
|
|
2016-03-15 |
2016-03-14 |
K
Kauf
|
GLAXOSMITHKLINE PLC
Large shareholder
|
1.301.015
+15.6%
23.027.965,50
29.959.728.534.983 USD
|
1.301.015
+15.6%
|
23.027.965,50
|
29.959.728.534.983 USD
|
|
|
2015-08-18 |
2015-08-18 |
K
Kauf
|
LEE JUNNING
Sr. VP, Technical Operations
Führungsperson
|
9.000
+inf%
12,90
116.100 USD
|
9.000
+inf%
|
12,90
|
116.100 USD
|
|
|
2015-08-18 |
2015-08-18 |
K
Kauf
|
MALKIEL BURTON G
Nicht geschäftsführender Verwaltungsratsmitglied
|
10.000
+94.6%
12,92
129.200 USD
|
10.000
+94.6%
|
12,92
|
129.200 USD
|
|
|
2015-08-17 |
2015-08-17 |
K
Kauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
5.000
+3.2%
12,16
60.800 USD
|
5.000
+3.2%
|
12,16
|
60.800 USD
|
|
|
2015-08-17 |
2015-08-17 |
K
Kauf
|
Winningham Rick E
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
16.860
+2.9%
12,13
204.512 USD
|
16.860
+2.9%
|
12,13
|
204.512 USD
|
|
|
2015-08-17 |
2015-08-14 |
K
Kauf
|
Winningham Rick E
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
63.140
+12.1%
11,79
744.421 USD
|
63.140
+12.1%
|
11,79
|
744.421 USD
|
|
|
2015-08-17 |
2015-08-13 |
K
Kauf
|
GALA RENEE D
SVP, Chief Financial Officer
Führungsperson
|
5.000
+3.3%
12,19
60.950 USD
|
5.000
+3.3%
|
12,19
|
60.950 USD
|
|
